Stock Earnings

Question 1

Vertex Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Vertex Pharmaceuticals Incの総資産は$22,533で、純lossは$-535です。

Question 2

VRTXの主要な財務比率は何ですか？

Accepted Answer

Vertex Pharmaceuticals Incの流動比率は3.68、純利益率は-4.85、1株当たり売上高は$42.72です。

Question 3

Vertex Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Vertex Pharmaceuticals Inc largest revenue segment is Other, at a revenue of 771,500,000 in the most earnings release.For geography, Other Collaborative and Royalty is the primary market for Vertex Pharmaceuticals Inc, at a revenue of 1,000,000.

Question 4

Vertex Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Vertex Pharmaceuticals Incの純lossは$-535です。

Question 5

Vertex Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、Vertex Pharmaceuticals Incの負債は6,123です。

Question 6

Vertex Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

Vertex Pharmaceuticals Incの総発行済株式数は256.94株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	11,723	11,020	9,869	8,930	7,574	6,205
Revenue Growth (YoY)	10%	12%	11%	18%	22%	49%
Cost of Revenue	1,608	1,530	1,262	1,080	904	736
Gross Profit	10,114	9,489	8,607	7,850	6,670	5,469
Selling, General & Admin	1,643	1,464	1,136	944	840	770
Research & Development	3,934	3,630	3,162	2,527	3,051	1,829
Operating Expenses	5,578	5,094	4,247	3,414	3,888	2,613
Other Non Operating Income (Expenses)	-21	-76	-15	-15	-12	160
Pretax Income	4,448	248	4,379	4,232	2,730	3,116
Income Tax Expense	773	784	760	910	388	405
Net Income	3,675	-535	3,619	3,322	2,342	2,711
Net Income Growth	-867%	-114.99%	9%	42%	-14%	131%
Shares Outstanding (Diluted)	257.6	257.9	260.5	259.1	259.9	263.39
Shares Change (YoY)	-1%	-1%	1%	0%	-1%	1%
EPS (Diluted)	14.26	-2.08	13.89	12.82	9.01	10.29
EPS Growth	-878.99%	-114.99%	8%	42%	-12%	128%
Free Cash Flow	3,337	-978	3,278	3,925	2,408	2,993
Free Cash Flow Per Share	12.95	-3.79	12.58	15.14	9.26	11.36
Gross Margin	86.27%	86.1%	87.21%	87.9%	88.06%	88.13%
Operating Margin	38.69%	39.88%	44.16%	49.66%	36.73%	46.02%
Profit Margin	31.34%	-4.85%	36.67%	37.2%	30.92%	43.69%
Free Cash Flow Margin	28.46%	-8.87%	33.21%	43.95%	31.79%	48.23%
EBITDA	4,736	4,602	4,540	4,583	2,907	2,965
EBITDA Margin	40.39%	41.76%	46%	51.32%	38.38%	47.78%
D&A For EBITDA	200	207	181	148	125	109
EBIT	4,536	4,395	4,359	4,435	2,782	2,856
EBIT Margin	38.69%	39.88%	44.16%	49.66%	36.73%	46.02%
Effective Tax Rate	17.37%	316.12%	17.35%	21.5%	14.21%	12.99%

Vertex Pharmaceuticals Inc (VRTX) Price

VRTX Stock Price Chart

VRTX Income

Follow-Up Questions